Skip to main content
SpringerLink
Log in

The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Peripheral T cell lymphomas (PTCL) are a rare and heterogeneous group of aggressive non-Hodgkin lymphomas, showing a generally poor prognosis. In this retrospective analysis, we aimed to investigate the impact of autologous stem cell transplantation (autoSCT) in PTCL.

Methods

A retrospective analysis of 58 consecutive unselected PTCL patients aged 21–71 years undergoing autoSCT as first-line consolidation as well as in the relapse setting was performed.

Results

The median follow-up time was 67 months. A 5-year overall survival (OS) of 53% and a 5-year progression-free survival (PFS) after autoSCT of 44% was achieved. The overall relapse rate after autoSCT was 50%. On multivariate analysis, standard baseline characteristics such as age, disease stage and international prognostic index (IPI) score failed to predict outcome in our cohort. First-line treatment with autoSCT was not associated with a benefit in OS when compared to patients receiving autoSCT at relapse. Notably, autoSCT seemed to be a suitable approach even for older transplant-eligible patients (aged ≥ 60 years), with a similar 5-year OS of 49% when compared to younger patients.

Conclusions

Our study suggests that autoSCT can achieve long-term survival in PTCL patients even after relapse and should also be considered for eligible older patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Advani S et al (1980) Immune dysfunction in non-Hodgkin’s lymphoma. Cancer 45:2843–2848

    Article  CAS  PubMed  Google Scholar 

  • Brugger W, Bross K, Frisch J, Dern P, Weber B, Mertelsmann R, Kanz L (1992) Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]. Blood 79:1193–1200

    Article  CAS  Google Scholar 

  • Cederleuf H et al (2017) Outcome of peripheral T cell lymphoma in first complete remission: a Danish–Swedish population-based study. Leuk Lymphoma 58:2815–2823

    Article  PubMed  Google Scholar 

  • Cheson BD et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. J Clin Oncol 17:1244

    Article  CAS  PubMed  Google Scholar 

  • Chihara D et al (2017) The survival outcome of patients with relapsed/refractory peripheral T cell lymphoma-not otherwise specified and angioimmunoblastic T cell lymphoma. Br J Haematol 176:750–758. https://doi.org/10.1111/bjh.14477

    Article  CAS  PubMed  Google Scholar 

  • Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon P, Diebold J (1990) Peripheral T cell lymphomas have a worse prognosis than B cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1:45–50

    Article  CAS  PubMed  Google Scholar 

  • Corradini P et al (2004) Graft-versus-lymphoma effect in relapsed peripheral T cell non-Hodgkin’s lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 22:2172–2176

    Article  PubMed  Google Scholar 

  • Corradini P et al (2006) Long-term follow-up of patients with peripheral T cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 20:1533

    Article  CAS  PubMed  Google Scholar 

  • d’Amore F et al (2006) Dose-dense induction followed by autologous stem cell transplant (ASCT) as 1st line treatment in peripheral T cell lymphomas (PTCL)-a phase II Study of the Nordic Lymphoma Group (NLG). Blood 108(11):401

    Article  Google Scholar 

  • d’Amore F et al (2012) Up-front autologous stem-cell transplantation in peripheral T cell lymphoma: NLG-T-01. J Clin Oncol 30:3093–3099

    Article  CAS  PubMed  Google Scholar 

  • d’Amore F et al (2015) Peripheral T cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26:v108–v115

    Article  PubMed  Google Scholar 

  • Dueck G et al (2010) Interim report of a phase 2 clinical trial of lenalidomide for T cell non-Hodgkin lymphoma. Cancer 116:4541–4548

    Article  CAS  PubMed  Google Scholar 

  • Ellin F, Landstrom J, Jerkeman M, Relander T (2014) Real-world data on prognostic factors and treatment in peripheral T cell lymphomas: a study from the Swedish Lymphoma Registry. Blood 124:1570–1577. https://doi.org/10.1182/blood-2014-04-573089

    Article  CAS  PubMed  Google Scholar 

  • Fanale MA et al (2014) Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T cell lymphomas: results of a phase I study. J Clin Oncol 32:3137

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K (2011) Peripheral T cell lymphoma. Blood 117:6756–6767. https://doi.org/10.1182/blood-2010-05-231548

    Article  CAS  PubMed  Google Scholar 

  • Fossard G et al (2017) Role of up-front autologous stem-cell transplantation in peripheral T cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers. Ann Oncol 29:715–723

    Article  Google Scholar 

  • Gallamini A et al (2007) Alemtuzumab (campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 110:2316–2323

    Article  CAS  PubMed  Google Scholar 

  • Gkotzamanidou M, Papadimitriou CA (2014) Peripheral T cell lymphoma: the role of hematopoietic stem cell transplantation. Crit Rev Oncol/Hematol 89:248–261

    Article  Google Scholar 

  • Gutiérrez-García G et al (2010) Comparison of four prognostic scores in peripheral T cell lymphoma. Ann Oncol 22:397–404

    Article  PubMed  Google Scholar 

  • Haas R et al (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787–3794

    Article  CAS  Google Scholar 

  • Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA, Devine SM (2008) Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas; evidence of graft-versus-T cell lymphoma effect. Biol Blood Marrow Transplant 14:480–483

    Article  PubMed  Google Scholar 

  • Horwitz SM et al (2014) Objective responses in relapsed T cell lymphomas with single agent brentuximab vedotin. Blood 123:3095–3100. https://doi.org/10.1182/blood-2013-2012-542142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jacquy C et al (2000) A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin’s lymphoma: one-half of patients significantly mobilize malignant cells. Br J Haematol 110:631–637

    Article  CAS  PubMed  Google Scholar 

  • Kanakry JA et al (2013) Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma. Biol Blood Marrow Transplant 19:602–606. https://doi.org/10.1016/j.bbmt.2013.01.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kharfan-Dabaja MA et al (2017) Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 23:1826–1838

    Article  PubMed  Google Scholar 

  • Le Gouill S et al (2008) Graft-versus-lymphoma effect for aggressive T cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 26:2264–2271. https://doi.org/10.1200/jco.2007.14.1366

    Article  PubMed  Google Scholar 

  • Mak V et al (2013) Survival of patients with peripheral T cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors. J Clin Oncol 31:1970–1976

    Article  CAS  PubMed  Google Scholar 

  • Moskowitz AJ, Lunning M, Horwitz SM (2014) How I treat the peripheral T cell lymphomas. Blood 123:2636–2644. https://doi.org/10.1182/blood-2013-2012-516245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nickelsen M et al (2009) High-dose CHOP plus etoposide (MegaCHOEP) in T cell lymphoma: a comparative analysis of patients treated within trials of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Ann Oncol 20:1977–1984

    Article  CAS  PubMed  Google Scholar 

  • Philip T et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 333:1540–1545

    Article  CAS  PubMed  Google Scholar 

  • Piccaluga PP, Agostinelli C, Gazzola A, Mannu C, Bacci F, Sabattini E, Pileri SA (2010) Prognostic markers in peripheral T cell lymphoma. Curr Hematol Malig Rep 5:222–228

    Article  PubMed  PubMed Central  Google Scholar 

  • Piekarz RL et al (2011) Phase 2 trial of romidepsin in patients with peripheral T cell lymphoma. Blood 117:5827–5834

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Project IT-CL (2008) International peripheral T cell and natural killer/T cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124–4130. https://doi.org/10.1200/jco.2008.16.4558

    Article  Google Scholar 

  • Reimer P et al (2009) Autologous stem-cell transplantation as first-line therapy in peripheral T cell lymphomas: results of a prospective multicenter study. J Clin Oncol 27:106–113

    Article  CAS  PubMed  Google Scholar 

  • Rodriguez J et al (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 18:652–657

    Article  CAS  PubMed  Google Scholar 

  • Rodríguez J et al (2007) Frontline autologous stem cell transplantation in high-risk peripheral T cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol 79:32–38

    Article  PubMed  Google Scholar 

  • Rohlfing S et al (2018) The impact of stem cell transplantation on the natural course of peripheral T cell lymphoma: a real-world experience. Ann Hematol 97:1241–1250. https://doi.org/10.1007/s00277-018-3288-7

    Article  PubMed  Google Scholar 

  • Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Contemp Clin Trials 17:343–346

    Article  CAS  Google Scholar 

  • Smith SM et al (2013) Hematopoietic cell transplantation for systemic mature T cell non-Hodgkin lymphoma. J Clin Oncol 31:3100

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No Funding was received for this study.

Author information

Author notes

  1. Malte Roerden and Juliane S. Walz contributed equally.

Authors and Affiliations

  1. Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Germany

    Malte Roerden, Juliane S. Walz, Martin R. Müller, Martin Sökler, Lothar Kanz, Wolfgang Bethge & Wichard Vogel

  2. Department of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany

    Birgit Federmann

Authors
  1. Malte Roerden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juliane S. Walz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin R. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martin Sökler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Birgit Federmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lothar Kanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Wolfgang Bethge
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wichard Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juliane S. Walz.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

432_2019_2999_MOESM1_ESM.docx

Supplementary Table S1 Peripheral blood stem cell harvest. CHO(E)P cyclophosphamide, doxorubicin, vincristine, (etoposide), prednisone, VACOP-B etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, bleomycin, DHAP dexamethasone, high-dose cytarabine, cisplatin, VIPE etoposide, ifosfamide, cisplatin, epirubicin, bw body weight (DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roerden, M., Walz, J.S., Müller, M.R. et al. The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience. J Cancer Res Clin Oncol 145, 2595–2604 (2019). https://doi.org/10.1007/s00432-019-02999-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-019-02999-9

Keywords

Search

Navigation